RU2003113127A - METHOD FOR EARLY GYROINTESTINAL BLEEDING THERAPY - Google Patents

Claims (1)

A method for the early treatment of gastrointestinal bleeding by introducing a 0.9% sodium chloride solution, 5% glucose solution with insulin, potassium chloride, calcium chloride, magnesium sulfate, dicinone, infucol, plasma, erythrocyte mass of single blood, vicasol, 20% glucose solution insulin holding inotropic stimulation, wherein the patient is further added 7.5% sodium chloride solution, or dalargin mildronat contrycal (gordoks), heparin, ascorbic acid, vitamin B _6, Riboxinum, pentamine and infusion therapy is performed predominantly crystalloid solutions, in this case, first, a 7.5% solution of sodium chloride 200-300 ml, dalargin 0.001-0.003 g or at a systolic blood pressure below 90 mm Hg are injected into the central vein - 10% -5-6 ml mildronate, then under by control of the central venous pressure, a 0.9% solution of sodium chloride 400 - 800 ml with dicinone 4-8 ml, 5% glucose solution 400-800 ml with insulin 6-12 IU and potassium chloride 4% solution - 20-30 ml, chloride are injected calcium 10% solution - 8-10 ml, magnesium sulfate 25% solution 4-6 ml, 0.9% sodium chloride solution 400 - 800 ml with contrycal (gordoksom) 20-40 t sach U, infucol 500-800 ml, single-group plasma 600-800 ml, heparin 3000-4000 UNITs intravenously in a 0.9% sodium chloride solution of 20 ml, then ascorbic acid 5% -4-6 ml is administered intravenously in a peripheral vein 40% glucose solution 15 ml, Riboxinum 8-10 ml intravenously, 0.9% sodium chloride solution 10 ml, Vitamin B _e 1-2 ml intravenously, 20 ml 0.9% sodium chloride solution, at the same time, vicasol is administered intramuscularly 1% solution of 4-6 ml, the introduction of a 20% glucose solution of 300-400 ml with insulin 20-26 units in the central vein is continued, blood transfusion is carried out erythrocyte mass of 400-600 ml, with unstable hemodynamics, intravenous administration of 0.9% sodium chloride solution with dopamine infusion of 5-10 mg / kg / min is continued, and after stabilization of hemodynamic parameters, correction of circulating blood volume, dalargin is administered intramuscularly at 0.001- 0.003 2 times a day, or the patient is prescribed 5-6 ml of mildronate 10% solution intravenously per 15 ml of 0.9% sodium chloride solution 1 time per day for 10-14 days and pentamine 5% solution 0.3-0, 5 ml intramuscularly 3 times a day for 3-5 days.